Literature DB >> 8012982

Loss of amplified c-myc genes in the spontaneously differentiated HL-60 cells.

N Shimizu1, H Nakamura, T Kadota, K Kitajima, T Oda, T Hirano, H Utiyama.   

Abstract

Amplification of the c-myc gene in the human promyelocytic leukemia cell line HL-60 is considered to be one of the major causes of its malignant phenotype. It is also well known since the establishment of the cell line that a culture of HL-60 cells contains a small but fixed percentage of spontaneously differentiated cells. We show that the spontaneous differentiation could be a result of extensive losses of amplified c-myc genes by the findings: (a) the spontaneously differentiated HL-60 cells express Mac-1 (CR3, CD11b/CD18) antigen, irreversibly stop the uptake of [3H]thymidine, and die by apoptosis; (b) these cells, when isolated, and when the copy number of c-myc genes is precisely quantitated, show extensive losses of c-myc genes; and (c) low concentrations of hydroxyurea increase the percentage of spontaneously differentiated cells in which the number of c-myc genes is further decreased. A simple theoretical consideration suggests that an active elimination process(es) must be operating besides the stochastic losses of the extrachromosomally amplified c-myc genes by unequal partition at mitosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012982

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Deregulated expression of c-Myc in a translocation-negative plasmacytoma on extrachromosomal elements that carry IgH and myc genes.

Authors:  F Wiener; T I Kuschak; S Ohno; S Mai
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronuclei.

Authors:  A Valent; J Bénard; B Clausse; M Barrois; D Valteau-Couanet; M J Terrier-Lacombe; B Spengler; A Bernheim
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

Review 3.  Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges.

Authors:  Imran Noorani; Paul S Mischel; Charles Swanton
Journal:  Nat Rev Clin Oncol       Date:  2022-09-21       Impact factor: 65.011

Review 4.  The genomic and spatial mobility of extrachromosomal DNA and its implications for cancer therapy.

Authors:  Eric van Leen; Lotte Brückner; Anton G Henssen
Journal:  Nat Genet       Date:  2022-02-10       Impact factor: 41.307

Review 5.  The contributions of extrachromosomal DNA elements in neoplasm progression.

Authors:  Jiawei Hong; Shusen Zheng; Donghai Jiang
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

6.  Gemcitabine eliminates double minute chromosomes from human ovarian cancer cells.

Authors:  Lisa Yu; Yan Zhao; Chao Quan; Wei Ji; Jing Zhu; Yun Huang; Rongwei Guan; Donglin Sun; Yan Jin; Xiangning Meng; Chunyu Zhang; Yang Yu; Jing Bai; Wenjing Sun; Songbin Fu
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

7.  Generation of micronuclei during interphase by coupling between cytoplasmic membrane blebbing and nuclear budding.

Authors:  Koh-ichi Utani; Atsushi Okamoto; Noriaki Shimizu
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

8.  Tracking of microinjected DNA in live cells reveals the intracellular behavior and elimination of extrachromosomal genetic material.

Authors:  Noriaki Shimizu; Fumie Kamezaki; Shiho Shigematsu
Journal:  Nucleic Acids Res       Date:  2005-11-03       Impact factor: 16.971

9.  Selective entrapment of extrachromosomally amplified DNA by nuclear budding and micronucleation during S phase.

Authors:  N Shimizu; N Itoh; H Utiyama; G M Wahl
Journal:  J Cell Biol       Date:  1998-03-23       Impact factor: 10.539

10.  Cell cycle synchronization and BrdU incorporation as a tool to study the possible selective elimination of ErbB1 gene in the micronuclei in A549 cells.

Authors:  C Lauand; E L Niero; V M Dias; G M Machado-Santelli
Journal:  Braz J Med Biol Res       Date:  2015-03-06       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.